(Q63598361)
Statements
A Prospective, Single Center, Open Label, Dose Escalation Phase I/IIa Study to Assess the Safety and Efficacy of an Intrathecal Administration of SCM-010 in Subjects With Secondary Progressive Multiple Sclerosis (SPMS) (English)
0 references
1 February 2019
0 references
1 February 2021
0 references
12
0 references
18 year
0 references
60 year
0 references